Role of IL-8, CRP and epidermal growth factor in depression and anxiety patients treated with mindfulness-based therapy or cognitive behavioral therapy in primary health care

Psychiatry Research

Volumn 254, Issue , 2017, Pages 311-316

  Memon, Ashfaque A ^a   Sundquist, Kristina ^a   Ahmad, Abrar ^a   Wang, Xiao ^a   Hedelius, Anna ^a   Sundquist, Jan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Biomarkers; Cytokines; Inflammation; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; TRANQUILIZER;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINDFULNESS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT HEALTH QUESTIONNAIRE 9; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TREATMENT RESPONSE; BLOOD; COGNITIVE THERAPY; GROUP THERAPY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; ANXIETY; C-REACTIVE PROTEIN; COGNITIVE THERAPY; DEPRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MINDFULNESS; PRIMARY HEALTH CARE; PSYCHOTHERAPY, GROUP; YOUNG ADULT;

EID: 85019053533     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2017.05.012     Document Type: Article

References (28)

1. Asberg, M., Nygren, A., Leopardi, R., Rylander, G., Peterson, U., Wilczek, L., Kallmen, H., Ekstedt, M., Akerstedt, T., Lekander, M., Ekman, R., Novel biochemical markers of psychosocial stress in women. PLoS One, 4, 2009, e3590.
2. Berardi, D., Berti Ceroni, G., Leggieri, G., Rucci, P., Ustun, B., Ferrari, G., Mental, physical and functional status in primary care attenders. Int J. Psychiatry Med. 29 (1999), 133–148.
3. Bodlund, O., Andersson, S.O., Mallon, L., Effects of consulting psychiatrist in primary care. 1-year follow-up of diagnosing and treating anxiety and depression. Scand. J. Prim. Health Care. 17 (1999), 153–157.
4. Chen-Plotkin, A.S., Hu, W.T., Siderowf, A., Weintraub, D., Goldmann Gross, R., Hurtig, H.I., Xie, S.X., Arnold, S.E., Grossman, M., Clark, C.M., Shaw, L.M., McCluskey, L., Elman, L., Van Deerlin, V.M., Lee, V.M., Soares, H., Trojanowski, J.Q., Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann. Neurol. 69 (2011), 655–663.
5. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67 (2010), 446–457.
6. Hannestad, J., DellaGioia, N., Bloch, M., The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36 (2011), 2452–2459.
7. Hannestad, J., DellaGioia, N., Ortiz, N., Pittman, B., Bhagwagar, Z., Citalopram reduces endotoxin-induced fatigue. Brain Behav. Immun. 25 (2011), 256–259.
8. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71 (2009), 171–186.
9. Kronfol, Z., Remick, D.G., Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157 (2000), 683–694.
10. Liukkonen, T., Rasanen, P., Jokelainen, J., Leinonen, M., Jarvelin, M.R., Meyer-Rochow, V.B., Timonen, M., The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study. Eur. Psychiatry 26 (2011), 363–369.
11. Luger, A., Calogero, A.E., Kalogeras, K., Gallucci, W.T., Gold, P.W., Loriaux, D.L., Chrousos, G.P., Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance. J. Clin. Endocrinol. Metab. 66 (1988), 334–337.
12. Maes, M., Lin, A.H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., Bosmans, E., Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 45 (1999), 833–839.
13. Memon, A.A., Sorensen, B.S., Melgard, P., Fokdal, L., Thykjaer, T., Nexo, E., Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br. J. Cancer 91 (2004), 2034–2041.
14. Moreira, F.P., Cardoso Tde, A., Mondin, T.C., Souza, L.D., Silva, R., Jansen, K., Oses, J.P., Wiener, C.D., The effect of proinflammatory cytokines in Cognitive Behavioral Therapy. J. Neuroimmunol. 285 (2015), 143–146.
15. Muller, N., Schwarz, M.J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Muller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Moller, H.J., Arolt, V., Riedel, M., The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11 (2006), 680–684.
16. Nexo, E., Hollenberg, M.D., Bing, J., Aggressive behavior in mice provokes a marked increase in both plasma epidermal growth factor and renin. Acta Physiol. Scand. 111 (1981), 367–371.
17. Nordstrom, A., Bodlund, O., Every third patient in primary care suffers from depression, anxiety or alcohol problems. Nord J. Psychiatry 62 (2008), 250–255.
18. Parikh, S.V., Lin, E., Lesage, A.D., Mental health treatment in Ontario: selected comparisons between the primary care and specialty sectors. Can. J. Psychiatry 42 (1997), 929–934.
19. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., Ridker, P.M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001), 327–334.
20. Raison, C.L., Borisov, A.S., Majer, M., Drake, D.F., Pagnoni, G., Woolwine, B.J., Vogt, G.J., Massung, B., Miller, A.H., Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol. Psychiatry 65 (2009), 296–303.
21. Remlinger-Molenda, A., Wojciak, P., Michalak, M., Rybakowski, J., Activity of selected cytokines in bipolar patients during manic and depressive episodes. Psychiatr. Pol. 46 (2012), 599–611.
22. Sundquist, J., Lilja, A., Palmer, K., Memon, A.A., Wang, X., Johansson, L.M., Sundquist, K., Mindfulness group therapy in primary care patients with depression, anxiety and stress and adjustment disorders: randomised controlled trial. Br. J. Psychiatry, 2014.
23. Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., Krishnan, R., Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006), 29–35.
24. Vazquez-Barquero, J.L., Garcia, J., Simon, J.A., Iglesias, C., Montejo, J., Herran, A., Dunn, G., Mental health in primary care. An epidemiological study of morbidity and use of health resources. Br. J. Psychiatry 170 (1997), 529–535.
25. Vogelzangs, N., Duivis, H.E., Beekman, A.T., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J.H., de Jonge, P., Penninx, B.W., Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry, 2, 2012, e79.
26. Wallensten, J., Asberg, M., Nygren, A., Szulkin, R., Wallen, H., Mobarrez, F., Nager, A., Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal Study. PLoS One, 11, 2016, e0153924.
27. Xian, C.J., Zhou, X.F., Roles of transforming growth factor-alpha and related molecules in the nervous system. Mol. Neurobiol. 20 (1999), 157–183.
28. Yamamori, H., Ishima, T., Yasuda, Y., Fujimoto, M., Kudo, N., Ohi, K., Hashimoto, K., Takeda, M., Hashimoto, R., Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population. Neurosci. Lett. 612 (2016), 167–171.